Brokerages Anticipate Danaher Co. (DHR) Will Announce Quarterly Sales of $4.81 Billion

Equities analysts expect that Danaher Co. (NYSE:DHR) will announce sales of $4.81 billion for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Danaher’s earnings, with the highest sales estimate coming in at $4.84 billion and the lowest estimate coming in at $4.75 billion. Danaher posted sales of $4.51 billion in the same quarter last year, which would indicate a positive year over year growth rate of 6.7%. The firm is scheduled to announce its next quarterly earnings report on Thursday, July 19th.

On average, analysts expect that Danaher will report full year sales of $19.51 billion for the current financial year, with estimates ranging from $19.34 billion to $19.91 billion. For the next fiscal year, analysts expect that the firm will report sales of $20.42 billion per share, with estimates ranging from $20.07 billion to $20.95 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that cover Danaher.

How to Become a New Pot Stock Millionaire

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, April 19th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.05. The business had revenue of $4.70 billion during the quarter, compared to analyst estimates of $4.54 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the business earned $0.85 EPS.

DHR has been the subject of a number of research reports. Evercore ISI initiated coverage on shares of Danaher in a report on Wednesday, January 3rd. They issued an “outperform” rating for the company. Royal Bank of Canada reiterated a “hold” rating and issued a $96.00 price objective on shares of Danaher in a report on Thursday, January 4th. Robert W. Baird reiterated a “buy” rating on shares of Danaher in a report on Friday, January 12th. Stifel Nicolaus reiterated a “buy” rating and issued a $110.00 price objective on shares of Danaher in a report on Friday, January 19th. Finally, UBS initiated coverage on shares of Danaher in a report on Monday, January 22nd. They issued a “buy” rating and a $99.97 price objective for the company. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $103.95.

NYSE DHR traded down $0.16 during trading hours on Friday, reaching $101.34. The company’s stock had a trading volume of 3,659,963 shares, compared to its average volume of 2,500,555. The firm has a market cap of $71,431.12, a PE ratio of 25.15, a price-to-earnings-growth ratio of 1.94 and a beta of 1.03. Danaher has a 52 week low of $78.97 and a 52 week high of $104.82. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05.

The company also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be issued a dividend of $0.16 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 28th. This represents a $0.64 annualized dividend and a yield of 0.63%. Danaher’s dividend payout ratio (DPR) is presently 15.88%.

In other news, insider Rainer Blair sold 3,981 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $100.05, for a total transaction of $398,299.05. Following the completion of the sale, the insider now owns 49,751 shares of the company’s stock, valued at approximately $4,977,587.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Daniel L. Comas sold 62,989 shares of Danaher stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the completion of the sale, the chief financial officer now directly owns 227,805 shares of the company’s stock, valued at approximately $23,226,997.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 313,260 shares of company stock valued at $31,657,786. Company insiders own 11.90% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vident Investment Advisory LLC bought a new stake in shares of Danaher during the 3rd quarter worth $417,000. Zions Bancorporation grew its holdings in Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after buying an additional 667 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in Danaher by 0.4% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 423,011 shares of the conglomerate’s stock valued at $36,286,000 after buying an additional 1,642 shares in the last quarter. Steward Partners Investment Advisory LLC purchased a new position in Danaher during the 3rd quarter valued at about $389,000. Finally, Chicago Partners Investment Group LLC grew its holdings in Danaher by 394.1% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 3,953 shares of the conglomerate’s stock valued at $339,000 after buying an additional 3,153 shares in the last quarter. 77.65% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Brokerages Anticipate Danaher Co. (DHR) Will Announce Quarterly Sales of $4.81 Billion” was published by Week Herald and is owned by of Week Herald. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://weekherald.com/2018/04/20/brokerages-anticipate-danaher-co-dhr-will-announce-quarterly-sales-of-4-81-billion.html.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Get a free copy of the Zacks research report on Danaher (DHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply